Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

por Lau-Min, Kelsey S., Varughese, Lisa A., Nelson, Maria N., Cambareri, Christine, Reddy, Nandi J., Oyer, Randall A., Teitelbaum, Ursina R., Tuteja, Sony
Publicado 2022

Role of Oncology Advanced Practitioners to Enhance Clinical Research

por Braun-Inglis, Christa, Boehmer, Leigh M., Zitella, Laura J., Hoffner, Brianna, Shvetsov, Yurii B., Berenberg, Jeffrey L., Oyer, Randall A., Benson, Al B.
Publicado 2022

Digital Health Applications in Oncology: An Opportunity to Seize

por Parikh, Ravi B, Basen-Enquist, Karen M, Bradley, Cathy, Estrin, Deborah, Levy, Mia, Lichtenfeld, J Leonard, Malin, Bradley, McGraw, Deven, Meropol, Neal J, Oyer, Randall A, Sheldon, Lisa Kennedy, Shulman, Lawrence N
Publicado 2022

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guid...

por Varughese, Lisa A., Bhupathiraju, Madhuri, Hoffecker, Glenda, Terek, Shannon, Harr, Margaret, Hakonarson, Hakon, Cambareri, Christine, Marini, Jessica, Landgraf, Jeffrey, Chen, Jinbo, Kanter, Genevieve, Lau-Min, Kelsey S., Massa, Ryan C., Damjanov, Nevena, Reddy, Nandi J., Oyer, Randall A., Teitelbaum, Ursina R., Tuteja, Sony
Publicado 2022

Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment

por Guerra, Carmen, Pressman, Alice, Hurley, Patricia, Garrett-Mayer, Elizabeth, Bruinooge, Suanna S., Howson, Alexandra, Kaltenbaugh, Melinda, Hanley Williams, Jen, Boehmer, Leigh, Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory, Crews, Jennie, Fashoyin-Aje, Lola, McCaskill-Stevens, Worta, Merrill, Janette, Nowakowski, Greg, Patel, Manali I., Ramirez, Amelie, Zwicker, Victoria, Oyer, Randall A., Pierce, Lori J.
Publicado 2023

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer

por Bange, Erin M., Han, Nicholas A., Wileyto, Paul, Kim, Justin Y., Gouma, Sigrid, Robinson, James, Greenplate, Allison R., Porterfield, Florence, Owoyemi, Olutosin, Naik, Karan, Zheng, Cathy, Galantino, Michael, Weisman, Ariel R., Ittner, Caroline A.G., Kugler, Emily M., Baxter, Amy E., Oniyide, Olutwatosin, Agyekum, Roseline S., Dunn, Thomas G., Jones, Tiffanie K., Giannini, Heather M., Weirick, Madison E., McAllister, Christopher M., Babady, N. Esther, Kumar, Anita, Widman, Adam J, DeWolf, Susan, Boutemine, Sawsan R, Roberts, Charlotte, Budzik, Krista R, Tollett, Susan, Wright, Carla, Perloff, Tara, Sun, Lova, Mathew, Divij, Giles, Josephine R., Oldridge, Derek A., Wu, Jennifer E., Alanio, Cécile, Adamski, Sharon, Garfall, Alfred L., Vella, Laura, Kerr, Samuel J., Cohen, Justine V., Oyer, Randall A., Massa, Ryan, Maillard, Ivan P., Maxwell, Kara N., Reilly, John P., Maslak, Peter G., Vonderheide, Robert H., Wolchok, Jedd D., Hensley, Scott E., Wherry, E. John, Meyer, Nuala, DeMichele, Angela M., Vardhana, Santosha A., Mamtani, Ronac, Huang, Alexander C.
Publicado 2021